1. A device review of Relivion®: an external combined occipital and trigeminal neurostimulation (eCOT-NS) system for self-administered treatment of migraine and major depressive disorder. (3rd April 2021) Authors: Daniel, Oved; Sharon, Roni; Tepper, Stewart J. Journal: Expert review of medical devices Issue: Volume 18:Number 4(2021) Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A narrative review of the importance of pharmacokinetics and drug–drug interactions of preventive therapies in migraine management. Issue 6 (2nd July 2021) Authors: Joshi, Shivang; Tepper, Stewart J.; Lucas, Sylvia; Rasmussen, Soeren; Nelson, Rob Journal: Headache Issue: Volume 61:Issue 6(2021) Page Start: 838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alcohol, Tobacco, Triggers, and Headache Disorders. Issue 7 (29th June 2015) Authors: Tepper, Stewart J. Journal: Headache Issue: Volume 55:Issue 7(2015) Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An Open‐Label Trial of a Sumatriptan Auto‐Injector for Migraine in Patients Currently Treated With Subcutaneous Sumatriptan3. Issue 1 (13th November 2012) Authors: Landy, Stephen H.; Tepper, Stewart J.; Wein, Theodore; Schweizer, Edward; Ramos, Elodie Journal: Headache Issue: Volume 53:Issue 1(2013) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Antiepilepsy Drugs in Migraine Prevention: Editorial. Issue 3 (1st March 2016) Authors: Tepper, Stewart J. Journal: Headache Issue: Volume 56:Issue 3(2016) Page Start: 601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Anti‐Calcitonin Gene‐Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018. (7th November 2018) Authors: Tepper, Stewart J. Journal: Headache Issue: Volume 58(2018)Supplement 3 Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AVP‐825 Breath‐Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks. Issue 5 (4th May 2015) Authors: Tepper, Stewart J.; Cady, Roger K.; Silberstein, Stephen; Messina, John; Mahmoud, Ramy A.; Djupesland, Per G.; Shin, Paul; Siffert, Joao Journal: Headache Issue: Volume 55:Issue 5(2015) Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials. Issue 7 (1st June 2019) Authors: Tepper, Stewart J.; Krege, John H.; Lombard, Louise; Asafu‐Adjei, Josephine K.; Dowsett, Sherie A.; Raskin, Joel; Buchanan, Andrew S.; Friedman, Deborah I. Journal: Headache Issue: Volume 59:Issue 7(2019) Page Start: 1052 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical Implications for Breath‐Powered Powder Sumatriptan Intranasal Treatment. Issue 8 (28th June 2013) Authors: Tepper, Stewart J. Journal: Headache Issue: Volume 53:Issue 8(2013) Page Start: 1341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cluster Headache: Potential Options for Medically Refractory Patients (When All Else Fails). Issue 7 (28th June 2013) Authors: Tepper, Stewart J.; Stillman, Mark J. Journal: Headache Issue: Volume 53:Issue 7(2013) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗